ARCHIVES

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

July 30, 2004

Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40.

May 1, 2009

FDA, HCFA Form Council On Biomedical Imaging.

November 10, 2000

NCI Okays Agreement Between Allegheny, Pitt, Over NSABP

February 3, 1995

New Ultrasound Technique For Hard To Diagnose Cysts

June 29, 2001

Breast Cancer Death Rates Improving, NCI Says

May 10, 1996